In 1998, Goldman Philanthropic Partners (GPP), a private operating foundation, was founded to accelerate the discovery of new treatments to improve the quality of life for people with catasrophic disease.  In 2005, Partnership for Cures was established as a 501(c)(3) public charity to carry on the GPP mission, bringing hope and supporting new directions through Rediscovery Research™.

Commitment:

• Alleviating suffering and bringing hope to those dealing with life-threatening illness.

• Challenging research institutions to support alternative approaches for research and funding that may lead to medical breakthroughs.

• Inspiring and funding researchers with innovative ideas that might otherwise remain unexplored.

• Honoring a donor's unique motivation to have an impact on the pursuit of treatments and cures.

Values:

• Accountability
  Partnership for Cures rigorously validates and manages research by requiring investigators to develop a Research Roadmap™. This report outlines the budget, time-line, and reporting requirements, as well as the outcome of goals and specific quarterly objectives.

• Collaboration
  Partnership for Cures creates collaborations between researchers,philanthropic investors, and physicians to get treatments to patients quickly.

• Urgency
  Partnership for Cures focuses on the urgency of getting treatments to patients while they are still healthy enough to benefit.